Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26441 http://scihub22266oqcxt.onion/10.1002/jmv.26441 32808695!7461450!32808695     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32808695&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Med+Virol 2021 ; 93 (3): 1489-1495 Nephropedia Template TP {{tp|p=32808695|t=2021. Bacterial infections and patterns of antibiotic use in patients with COVID-19 |pdf=|usr=}}{{32808695}} gab.com Text Bacterial infections and patterns of antibiotic use in patients with COVID-19 JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32808695 #FOAvip Bacterial coinfection is associated with poor outcomes in patients with viral pneumonia, but data on its role in the mortality of patients with coronavirus disease 2019 (COVID-19) is limited. This is a single-center retrospective analysis of 242 patients with confirmed COVID-19 admitted to both intensive care and non-intensive care settings. Bacterial coinfection was determined by the presence of characteristic clinical features and positive culture results. Multivariable logistic regression was used to analyze the association of concomitant bacterial infection with inpatient death after adjusting for demographic factors and comorbidities. Antibiotic use pattern was also determined. Bacterial coinfection was detected in 46 (19%) patients. Genitourinary source was the most frequent, representing 57% of all coinfections. The overall mortality rate was 21%. Concomitant bacterial infections were independently associated with increased inpatient mortality (OR, 5.838; 95% CI, 2.647-12.876). Patients with bacterial coinfection were relatively older (71.35 +/- 11.20 vs 64.78 +/- 15.23; P = .006). A total of 67% of patients received antibiotic therapy, yet 72% did not have an obvious source of bacterial infection. There was a significantly higher rate of inpatient mortality in patients who received antibiotics compared to those who did not (30% vs 5%; P < .0001). Bacterial coinfection in COVID-19 is associated with increased mortality. Twit Text FOAVip Bacterial infections and patterns of antibiotic use in patients with COVID-19 ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32808695 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32808695 #FOAvip English Wikipedia <ref>{{Cite pmid|32808695}}</ref> Bacterial infections and patterns of antibiotic use in patients with COVID-19 #MMPMID32808695 Goncalves Mendes Neto A; Lo KB; Wattoo A; Salacup G; Pelayo J; DeJoy R 3rd; Bhargav R; Gul F; Peterson E; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z J Med Virol 2021[Mar]; 93 (3): 1489-1495 PMID32808695show ga Bacterial coinfection is associated with poor outcomes in patients with viral pneumonia, but data on its role in the mortality of patients with coronavirus disease 2019 (COVID-19) is limited. This is a single-center retrospective analysis of 242 patients with confirmed COVID-19 admitted to both intensive care and non-intensive care settings. Bacterial coinfection was determined by the presence of characteristic clinical features and positive culture results. Multivariable logistic regression was used to analyze the association of concomitant bacterial infection with inpatient death after adjusting for demographic factors and comorbidities. Antibiotic use pattern was also determined. Bacterial coinfection was detected in 46 (19%) patients. Genitourinary source was the most frequent, representing 57% of all coinfections. The overall mortality rate was 21%. Concomitant bacterial infections were independently associated with increased inpatient mortality (OR, 5.838; 95% CI, 2.647-12.876). Patients with bacterial coinfection were relatively older (71.35 +/- 11.20 vs 64.78 +/- 15.23; P = .006). A total of 67% of patients received antibiotic therapy, yet 72% did not have an obvious source of bacterial infection. There was a significantly higher rate of inpatient mortality in patients who received antibiotics compared to those who did not (30% vs 5%; P < .0001). Bacterial coinfection in COVID-19 is associated with increased mortality. |Aged[MESH] |Anti-Bacterial Agents/*therapeutic use[MESH] |Bacterial Infections/*complications/*drug therapy/mortality[MESH] |COVID-19/*complications/*mortality[MESH] |Coinfection/*mortality[MESH] |Female[MESH] |Hospitalization[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Male[MESH]Bacterial infections and patterns of antibiotic use in patients with C(epmc).pdf DeepDyve Pubget Overpricing